SUNVANISH- hydroquinone cream 
Genesis Pharmaceutical, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Glytone skin Bleaching sunvanish



Dosage Apply SunVanish in the morning to the affected area or as directed by your physician.



Warnings Contains sodium Metabisulfite, a sulfite that may cause serious allergic type reactions (eg hives, itching, wheezing, anaphylaxis, severe asthma attack) in certain susceptible persons.

For external use only



Distributed by

Genesis Pharmaceuticals Inc

Parsippany, NJ  07054

Made in USA

18004598663

www.glytone.com



Keep out of reach of children



Contains Each gram of SunVanish contains 40 mg of hydroquinone USP, 75 mg of octinoxate and 50 mg of oxybenzone in a cream base of purified water, proplyene glycol, cetostearyl alcohol, glycerin, isopropyl palmitate, sodium metabisulfite, sodium lauryl sulfate, and sorbic acid

sunvanish label


Glytone skin bleaching sunvanish with sunscreen

hydroquinone USP, 4%

RX only

Net wt 2 oz (56 g)

SUNVANISH 
hydroquinone cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:64760-201
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HYDROQUINONE (HYDROQUINONE) HYDROQUINONE40 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
WATER 
PROPYLENE GLYCOL 
CETOSTEARYL ALCOHOL 
GLYCERIN 
ISOPROPYL PALMITATE 
SODIUM METABISULFITE 
SODIUM LAURYL SULFATE 
SORBIC ACID 
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:64760-201-011 in 1 BOX
156 g in 1 TUBE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER10/01/200908/20/2014
Labeler - Genesis Pharmaceutical, Inc. (117196928)

Revised: 7/2014
Document Id: b57c1257-52a8-43bb-abd8-109734292f20
Set id: 7f285b34-6600-4fda-a58e-4bd157b68c75
Version: 4
Effective Time: 20140730
 
Genesis Pharmaceutical, Inc.